$ARDX trading below cash – upgrade from CITI

$ARDX – the company has $118M cash, which means that they are trading below cash. The company already has one approved drug, and the company to issue a formal dispute resolution request (FDRR) on their last CRL. Price target from Citi is $13 and Ladenburg is showing $6.

Price Target

Also, the stock is sitting around 12% short interest, which is not immaterial.

Stock is at the bottom of its chart. Does this get $13? Probably not, but it is easily worth $5. IMHO really good risk reward.

I am long 20k shares. Hoping for the best!